A role for peripheral afferents in the pathophysiology and treatment of at-level neuropathic pain in spinal cord injury? A case report

@article{Wasner2007ARF,
  title={A role for peripheral afferents in the pathophysiology and treatment of at-level neuropathic pain in spinal cord injury? A case report},
  author={G. Wasner and D. Naleschinski and R. Baron},
  journal={Pain},
  year={2007},
  volume={131},
  pages={219-225}
}
Abstract At‐level neuropathic pain is a frequent symptom following spinal cord injury, but the underlying pathophysiology is not completely understood. We report a patient suffering from treatment‐resistant at‐level pain characterized by ongoing pain and mechanical allodynia for three years after an incomplete spinal lesion. Quantitative sensory testing revealed severe thermosensory deficits in the neuropathic pain area. However, topical application of capsaicin in the neuropathic pain area… Expand
26 Citations
Residual spinothalamic tract pathways predict development of central pain after spinal cord injury.
Combination Drug Therapy for Pain following Chronic Spinal Cord Injury
Lidocaine 5% Medicated Plaster for Spinal Neuropathic Pain
...
1
2
3
...

References

SHOWING 1-10 OF 59 REFERENCES
Sensory function in spinal cord injury patients with and without central pain.
Intravenous Lidocaine Relieves Spinal Cord Injury Pain: A Randomized Controlled Trial
Rodent model of chronic central pain after spinal cord contusion injury and effects of gabapentin.
Spinal cord injury pain – mechanisms and treatment
New Analgesics for Neuropathic Pain: The Lidocaine Patch
  • C. Argoff
  • Medicine
  • The Clinical journal of pain
  • 2000
...
1
2
3
4
5
...